Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 24409

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Calcitonin is a peptide hormone that lowers blood calcium levels and inhibits bone resorption.1 It belongs to the calcitonin family of peptides, which also includes amylin (Item No. 24274), calcitonin gene-related peptide (Item No. 24405), and adrenomedullin.2 The binding of human calcitonin to the calcitonin receptor (CTR) is modulated by receptor activity-modifying proteins (RAMPs).3 Calcitonin binds to CTR2 with IC50 values of 8.5, 6.2, 10.7, and 5.8 nM alone and with RAMP1, 2, or 3, respectively. It induces cAMP accumulation in rabbit aortic endothelial cells (RAECs) expressing CTR2 alone, or co-transfected with RAMP1, 2, or 3 (EC50s = 0.07, 0.08, 0.05, and 0.99 nM, respectively). In a bone resorption assay, human calcitonin inhibits pit formation in dentine by human giant cell tumor (GCT) cells, rabbit osteoclasts, and mouse osteoclasts (ID50s = 0.19, 0.032, and 0.21 nM, respectively).4
WARNING This product is not for human or veterinary use.
1. Calcitonin. A review of experimental and clinical investigations. Postgrad. Med. J. 44(511), 411-422 (1968).
2. Amylin, calcitonin gene-
3. An amylin receptor is revealed following co-
4. Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin. Calcif. Tissue Int. 59(2), 100-104 (1996).